223 related articles for article (PubMed ID: 37547211)
1. Neuroanatomical changes of ionotropic glutamatergic and GABAergic receptor densities in male mice modeling idiopathic and syndromic autism spectrum disorder.
Nardi L; Chhabra S; Leukel P; Krueger-Burg D; Sommer CJ; Schmeisser MJ
Front Psychiatry; 2023; 14():1199097. PubMed ID: 37547211
[TBL] [Abstract][Full Text] [Related]
2. Striatal increase of dopamine receptor 2 density in idiopathic and syndromic mouse models of autism spectrum disorder.
Chhabra S; Nardi L; Leukel P; Sommer CJ; Schmeisser MJ
Front Psychiatry; 2023; 14():1110525. PubMed ID: 36970280
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of Cell Surface Glutamate and GABA Receptor Expression in Shank and CNTN4 Autism Mouse Models.
Heise C; Preuss JM; Schroeder JC; Battaglia CR; Kolibius J; Schmid R; Kreutz MR; Kas MJH; Burbach JPH; Boeckers TM
Front Mol Neurosci; 2018; 11():212. PubMed ID: 29970989
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional d-aspartate metabolism in BTBR mouse model of idiopathic autism.
Nuzzo T; Sekine M; Punzo D; Miroballo M; Katane M; Saitoh Y; Galbusera A; Pasqualetti M; Errico F; Gozzi A; Mothet JP; Homma H; Usiello A
Biochim Biophys Acta Proteins Proteom; 2020 Dec; 1868(12):140531. PubMed ID: 32853769
[TBL] [Abstract][Full Text] [Related]
5. Developmental Changes of Glutamate and GABA Receptor Densities in Wistar Rats.
Behuet S; Cremer JN; Cremer M; Palomero-Gallagher N; Zilles K; Amunts K
Front Neuroanat; 2019; 13():100. PubMed ID: 31920569
[TBL] [Abstract][Full Text] [Related]
6.
Yoo T; Cho H; Park H; Lee J; Kim E
Front Cell Neurosci; 2019; 13():458. PubMed ID: 31649512
[TBL] [Abstract][Full Text] [Related]
7. Kami-shoyo-san ameliorates sociability deficits in ovariectomized mice, a putative female model of autism spectrum disorder, via facilitating dopamine D
Guo Q; Ebihara K; Fujiwara H; Toume K; Awale S; Araki R; Yabe T; Dong E; Matsumoto K
J Ethnopharmacol; 2019 May; 236():231-239. PubMed ID: 30862522
[TBL] [Abstract][Full Text] [Related]
8. Autism-associated Shank3 mutations alter mGluR expression and mGluR-dependent but not NMDA receptor-dependent long-term depression.
Lee K; Vyas Y; Garner CC; Montgomery JM
Synapse; 2019 Aug; 73(8):e22097. PubMed ID: 30868621
[TBL] [Abstract][Full Text] [Related]
9. Generational synaptic functions of GABA
Chu MC; Wu HF; Lee CW; Chung YJ; Chi H; Chen PS; Lin HC
J Biomed Sci; 2022 Jul; 29(1):51. PubMed ID: 35821032
[TBL] [Abstract][Full Text] [Related]
10. New boundaries and dissociation of the mouse hippocampus along the dorsal-ventral axis based on glutamatergic, GABAergic and catecholaminergic receptor densities.
Lothmann K; Deitersen J; Zilles K; Amunts K; Herold C
Hippocampus; 2021 Jan; 31(1):56-78. PubMed ID: 32986281
[TBL] [Abstract][Full Text] [Related]
11. Maturation of nucleus accumbens synaptic transmission signals a critical period for the rescue of social deficits in a mouse model of autism spectrum disorder.
Matthiesen M; Khlaifia A; Steininger CFD; Dadabhoy M; Mumtaz U; Arruda-Carvalho M
Mol Brain; 2023 May; 16(1):46. PubMed ID: 37226266
[TBL] [Abstract][Full Text] [Related]
12. Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism.
Rhine MA; Parrott JM; Schultz MN; Kazdoba TM; Crawley JN
Autism Res; 2019 Mar; 12(3):401-421. PubMed ID: 30653853
[TBL] [Abstract][Full Text] [Related]
13. Increased Dopamine Type 2 Gene Expression in the Dorsal Striatum in Individuals With Autism Spectrum Disorder Suggests Alterations in Indirect Pathway Signaling and Circuitry.
Brandenburg C; Soghomonian JJ; Zhang K; Sulkaj I; Randolph B; Kachadoorian M; Blatt GJ
Front Cell Neurosci; 2020; 14():577858. PubMed ID: 33240045
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autism.
Han S; Tai C; Jones CJ; Scheuer T; Catterall WA
Neuron; 2014 Mar; 81(6):1282-1289. PubMed ID: 24656250
[TBL] [Abstract][Full Text] [Related]
15. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism.
Kim JW; Seung H; Kim KC; Gonzales ELT; Oh HA; Yang SM; Ko MJ; Han SH; Banerjee S; Shin CY
Neuropharmacology; 2017 Feb; 113(Pt A):71-81. PubMed ID: 27638451
[TBL] [Abstract][Full Text] [Related]
16. GABAergic System Dysfunction in Autism Spectrum Disorders.
Zhao H; Mao X; Zhu C; Zou X; Peng F; Yang W; Li B; Li G; Ge T; Cui R
Front Cell Dev Biol; 2021; 9():781327. PubMed ID: 35198562
[TBL] [Abstract][Full Text] [Related]
17. Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders.
Tallarico M; Leo A; Russo E; Citraro R; Palma E; De Sarro G
Front Pharmacol; 2023; 14():1155729. PubMed ID: 37153775
[No Abstract] [Full Text] [Related]
18. Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains.
Mishra A; Singla R; Kumar R; Sharma A; Joshi R; Sarma P; Kaur G; Prajapat M; Bhatia A; Medhi B
ACS Chem Neurosci; 2022 Oct; 13(20):2942-2961. PubMed ID: 36166499
[TBL] [Abstract][Full Text] [Related]
19. Increased prefrontal GABA concentrations in adults with autism spectrum disorders.
Maier S; Düppers AL; Runge K; Dacko M; Lange T; Fangmeier T; Riedel A; Ebert D; Endres D; Domschke K; Perlov E; Nickel K; Tebartz van Elst L
Autism Res; 2022 Jul; 15(7):1222-1236. PubMed ID: 35587691
[TBL] [Abstract][Full Text] [Related]
20. Retinal alterations in a pre-clinical model of an autism spectrum disorder.
Guimarães-Souza EM; Joselevitch C; Britto LRG; Chiavegatto S
Mol Autism; 2019; 10():19. PubMed ID: 31011411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
